ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
Latest Information Update: 06 Apr 2022
At a glance
- Drugs Tacrolimus (Primary)
- Indications Diabetes mellitus; Glucose intolerance; Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ENTREAT
- 21 Mar 2022 Planned initiation date changed from 1 Aug 2021 to 31 Jan 2022.
- 21 Mar 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Jul 2021 New trial record